netherlands france united-kingdom

PHELIM

2

Auction closed!

Sold to Ireland
° Date of birth: 11-06-2020
Gender : Stallion
Color : Chestnut
Studbook: KWPN
With VAT: No
Location of the horse: Netherlands
LIVIUS
BORDEAUX
UNITED
VENNA
STB STER, PREFERENT, PRESTATIE
BLUEBERRY-UTOPIA
STB ELITE, SPORT-(DR), IBOP-(DR), PROK
VIVALDI
LADY-UTOPIA
STB STER, PREFERENT, PRESTATIE
HUMERALDA
SANTANO
SANDRO HIT
P.SILTANA VAN HOF OLYMPIA
STB STER, PREFERENT, PRESTATIE, PROK
UMERALDA
STB STER, VOORLOPIG KEUR
METALL
JESMERALDA
STB STER, PREFERENT

Info

Phelim
Livius is the result of the proven dressage inheritors Bordeaux and Vivaldi. This blood continuous to give a better dressage horse. During the spring-inspection of 2019, Livius got the highest score and managed to get a 9 for his rideability and attitude! He is combined with the Santano-daughter Humeralda, a half-sister of two Medium advanced horses. From this same damline several sport horses and also the international Grand Prix horse Bosley B (s.Diamond Hit) of Jonna Schelstraete, the Grand Prix horse Dreamboat BCN (s.Voice), and the Medium advanced horses Zagalon S. Flemmings (s.Flemmingh) and Pavarottie (s.Ircolando) are bred. The promising blood of Livius is combined with these Grand Prix genes!

 

 

2. PHELIM             528003202005102, VB, DP, 11-06-2020 , DONKERE VOS , HENGST

         V. LIVIUS V. BORDEAUX KEUR

         M. HUMERALDA DP STB-EXT

                   V. SANTANO M. UMERALDA RP STB STER, VOORLOPIG KEUR

                   MV. METALL -- EL CORONA

         FOK./GER.: S. D. VAN DEN HEUIJ- DEGEN, ELSENPAS 3, 6644 KP EWIJK

MM:

169CM

AMERALDA (V.KRACK C ) DR NED Z1

BRASIL (V.KRACK C ) DR NED Z1

 

MMM:

163CM

NIRALDA (V.JAZZ ) DR NED Z2

GM BOSLEY B (V.DIAMOND HIT ) DR INT GP JONNA SCHELSTRAETE (NED)

GM FIRALDA (V.OSCAR ) DR NED Z2 #GM ZAGALÓN S. FLEMMINGS (V. FLEMMINGH ) DR NED ZZL

 

MMMM:

167CM

PAVAROTTIE (V.IRCOLANDO ) DR NED ZZL

 


This website uses cookies. This way we can ensure that your browsing experience is made even more pleasant. For more information, please review its Privacy Policy.